359 related articles for article (PubMed ID: 14644997)
1. Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis.
Loh ML; Vattikuti S; Schubbert S; Reynolds MG; Carlson E; Lieuw KH; Cheng JW; Lee CM; Stokoe D; Bonifas JM; Curtiss NP; Gotlib J; Meshinchi S; Le Beau MM; Emanuel PD; Shannon KM
Blood; 2004 Mar; 103(6):2325-31. PubMed ID: 14644997
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia.
Niihori T; Aoki Y; Ohashi H; Kurosawa K; Kondoh T; Ishikiriyama S; Kawame H; Kamasaki H; Yamanaka T; Takada F; Nishio K; Sakurai M; Tamai H; Nagashima T; Suzuki Y; Kure S; Fujii K; Imaizumi M; Matsubara Y
J Hum Genet; 2005; 50(4):192-202. PubMed ID: 15834506
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells.
Schubbert S; Lieuw K; Rowe SL; Lee CM; Li X; Loh ML; Clapp DW; Shannon KM
Blood; 2005 Jul; 106(1):311-7. PubMed ID: 15761018
[TBL] [Abstract][Full Text] [Related]
4. PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group.
Loh ML; Reynolds MG; Vattikuti S; Gerbing RB; Alonzo TA; Carlson E; Cheng JW; Lee CM; Lange BJ; Meshinchi S;
Leukemia; 2004 Nov; 18(11):1831-4. PubMed ID: 15385933
[TBL] [Abstract][Full Text] [Related]
5. Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factor.
Chan RJ; Leedy MB; Munugalavadla V; Voorhorst CS; Li Y; Yu M; Kapur R
Blood; 2005 May; 105(9):3737-42. PubMed ID: 15644411
[TBL] [Abstract][Full Text] [Related]
6. Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia.
Tartaglia M; Martinelli S; Cazzaniga G; Cordeddu V; Iavarone I; Spinelli M; Palmi C; Carta C; Pession A; Aricò M; Masera G; Basso G; Sorcini M; Gelb BD; Biondi A
Blood; 2004 Jul; 104(2):307-13. PubMed ID: 14982869
[TBL] [Abstract][Full Text] [Related]
7. The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease.
Kratz CP; Niemeyer CM; Castleberry RP; Cetin M; Bergsträsser E; Emanuel PD; Hasle H; Kardos G; Klein C; Kojima S; Stary J; Trebo M; Zecca M; Gelb BD; Tartaglia M; Loh ML
Blood; 2005 Sep; 106(6):2183-5. PubMed ID: 15928039
[TBL] [Abstract][Full Text] [Related]
8. SHP-2 and myeloid malignancies.
Tartaglia M; Niemeyer CM; Shannon KM; Loh ML
Curr Opin Hematol; 2004 Jan; 11(1):44-50. PubMed ID: 14676626
[TBL] [Abstract][Full Text] [Related]
9. Mutations of the PTPN11 and RAS genes in rhabdomyosarcoma and pediatric hematological malignancies.
Chen Y; Takita J; Hiwatari M; Igarashi T; Hanada R; Kikuchi A; Hongo T; Taki T; Ogasawara M; Shimada A; Hayashi Y
Genes Chromosomes Cancer; 2006 Jun; 45(6):583-91. PubMed ID: 16518851
[TBL] [Abstract][Full Text] [Related]
10. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
Fragale A; Tartaglia M; Wu J; Gelb BD
Hum Mutat; 2004 Mar; 23(3):267-77. PubMed ID: 14974085
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11.
Flotho C; Steinemann D; Mullighan CG; Neale G; Mayer K; Kratz CP; Schlegelberger B; Downing JR; Niemeyer CM
Oncogene; 2007 Aug; 26(39):5816-21. PubMed ID: 17353900
[TBL] [Abstract][Full Text] [Related]
12. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.
Bentires-Alj M; Paez JG; David FS; Keilhack H; Halmos B; Naoki K; Maris JM; Richardson A; Bardelli A; Sugarbaker DJ; Richards WG; Du J; Girard L; Minna JD; Loh ML; Fisher DE; Velculescu VE; Vogelstein B; Meyerson M; Sellers WR; Neel BG
Cancer Res; 2004 Dec; 64(24):8816-20. PubMed ID: 15604238
[TBL] [Abstract][Full Text] [Related]
13. PTPN11, RAS and FLT3 mutations in childhood acute lymphoblastic leukemia.
Yamamoto T; Isomura M; Xu Y; Liang J; Yagasaki H; Kamachi Y; Kudo K; Kiyoi H; Naoe T; Kojma S
Leuk Res; 2006 Sep; 30(9):1085-9. PubMed ID: 16533526
[TBL] [Abstract][Full Text] [Related]
14. Mutations of PTPN11 are rare in adult myeloid malignancies.
Hugues L; Cavé H; Philippe N; Pereira S; Fenaux P; Preudhomme C
Haematologica; 2005 Jun; 90(6):853-4. PubMed ID: 15951301
[TBL] [Abstract][Full Text] [Related]
15. Somatic PTPN11 mutations in childhood acute myeloid leukaemia.
Tartaglia M; Martinelli S; Iavarone I; Cazzaniga G; Spinelli M; Giarin E; Petrangeli V; Carta C; Masetti R; Aricò M; Locatelli F; Basso G; Sorcini M; Pession A; Biondi A
Br J Haematol; 2005 May; 129(3):333-9. PubMed ID: 15842656
[TBL] [Abstract][Full Text] [Related]
16. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia.
Tartaglia M; Niemeyer CM; Fragale A; Song X; Buechner J; Jung A; Hählen K; Hasle H; Licht JD; Gelb BD
Nat Genet; 2003 Jun; 34(2):148-50. PubMed ID: 12717436
[TBL] [Abstract][Full Text] [Related]
17. Gene transfer of SHIP-1 inhibits proliferation of juvenile myelomonocytic leukemia cells carrying KRAS2 or PTPN11 mutations.
Metzner A; Horstmann MA; Fehse B; Ortmeyer G; Niemeyer CM; Stocking C; Mayr GW; Jücker M
Gene Ther; 2007 Apr; 14(8):699-703. PubMed ID: 17268534
[TBL] [Abstract][Full Text] [Related]
18. Effects of a leukemia-associated gain-of-function mutation of SHP-2 phosphatase on interleukin-3 signaling.
Yu WM; Daino H; Chen J; Bunting KD; Qu CK
J Biol Chem; 2006 Mar; 281(9):5426-34. PubMed ID: 16371368
[TBL] [Abstract][Full Text] [Related]
19. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis.
Zhang Z; Jimi E; Bothwell AL
J Immunol; 2003 Oct; 171(7):3620-6. PubMed ID: 14500659
[TBL] [Abstract][Full Text] [Related]
20. PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome.
Binder G; Neuer K; Ranke MB; Wittekindt NE
J Clin Endocrinol Metab; 2005 Sep; 90(9):5377-81. PubMed ID: 15985475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
